1. Peck WA, Burckhardt P, Christiansen C, et al. Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993; 94:646–650.
2. Kang BJ, Lee YK, Lee KW, et al. Mortality after hip fractures in nonagenarians. J Bone Metab. 2012; 19:83–86.
3. Yoon HK, Park C, Jang S, et al. Incidence and mortality following hip fracture in Korea. J Korean Med Sci. 2011; 26:1087–1092.
4. Lee YK, Jang S, Jang S, et al. Mortality after vertebral fracture in Korea: analysis of the National Claim Registry. Osteoporos Int. 2012; 23:1859–1865.
5. Park C, Ha YC, Jang S, et al. The incidence and residual lifetime risk of osteoporosis-related fractures in Korea. J Bone Miner Metab. 2011; 29:744–751.
6. Johnell O, Kanis JA, Oden A, et al. Predictive value of BMD for hip and other fractures. J Bone Miner Res. 2005; 20:1185–1194.
7. Lim LS, Hoeksema LJ, Sherin K, et al. Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice. Am J Prev Med. 2009; 36:366–375.
8. Cadarette SM, Jaglal SB, Kreiger N, et al. Development and validation of the Osteoporosis Risk Assessment Instrument to facilitate selection of women for bone densitometry. CMAJ. 2000; 162:1289–1294.
9. Salaffi F, Silveri F, Stancati A, et al. Development and validation of the osteoporosis prescreening risk assessment (OPERA) tool to facilitate identification of women likely to have low bone density. Clin Rheumatol. 2005; 24:203–211.
10. Middleton RG, Shabani F, Uzoigwe CE, et al. FRAX and the assessment of the risk of developing a fragility fracture. J Bone Joint Surg Br. 2012; 94:1313–1320.
11. Min YK, Lee DY, Park YS, et al. A FRAX Experience in Korea: fracture risk probabilities with a country-specific versus a surrogate model. J Bone Metab. 2015; 22:113–118.
12. Barrett-Connor E, Siris ES, Wehren LE, et al. Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res. 2005; 20:185–194.
14. Shin C, Abbott RD, Lee H, et al. Prevalence and correlates of orthostatic hypotension in middle-aged men and women in Korea: the Korean Health and Genome Study. J Hum Hypertens. 2004; 18:717–723.
15. Han JH, Park HS, Kim JA, et al. Apolipoprotein B is a better marker than non-HDL-cholesterol for the metabolic syndrome in Koreans. Atherosclerosis. 2008; 197:333–338.
16. Hung LK, Wu HT, Leung PC, et al. Low BMD is a risk factor for low-energy Colles' fractures in women before and after menopause. Clin Orthop Relat Res. 2005; 219–225.
17. Siris ES, Miller PD, Barrett-Connor E, et al. Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment. JAMA. 2001; 286:2815–2822.
18. Cawthon PM, Ewing SK, Mackey DC, et al. Change in hip bone mineral density and risk of subsequent fractures in older men. J Bone Miner Res. 2012; 27:2179–2188.
19. Lau EM, Woo J, Leung PC, et al. Low bone mineral density, grip strength and skinfold thickness are important risk factors for hip fracture in Hong Kong Chinese. Osteoporos Int. 1993; 3:66–70.
20. Kanis JA, Johnell O, De Laet C, et al. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res. 2002; 17:1237–1244.
21. Kanis JA, Odén A, McCloskey EV, et al. A systematic review of hip fracture incidence and probability of fracture worldwide. Osteoporos Int. 2012; 23:2239–2256.